Sign in Pull a receipt

CYDY

CytoDyn Inc.

Healthcare · Biotechnology

$172.00 sample

+0.78 (+0.46%) 1D

Market cap

$1.01T

Price as of

2026-10-29

Latest filing

8-K · 2026-10-06

Alerts

8

Price$172.00 +12.76% 3M daily closessample

174.36149.01

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 21INSInsider sell: General Counsel
Oct 14INSInsider buy: Chief Financial Officer
Oct 06SEC8-K filed: material event
Sep 29INSInsider buy: Director
Sep 21INSInsider sell: General Counsel
Sep 14INSInsider sell: EVP, Operations
Sep 03SECForm 144 filed
Aug 28INSInsider sell: Chief Financial Officer

Sign up to see the real CYDY record →

Company facts

SEC EDGAR registration

Name: CytoDyn Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -58sample, -100 to +100
Reporting currency: USD

Who is positioning in CYDY

sample

Insiders: 16 insider transactions over 90 days, net selling, $94.6M
Congress: 3 members traded over 90 days
Institutions · 13F: 39 funds hold $11.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$30.8B +21.0% y/y

Q4 2024Q3 2026

Inventory$18.1B +13.6% y/y

Q4 2024Q3 2026

Accounts receivable$13.1B +3.3% y/y

Q4 2024Q3 2026

Total debt$37.1B +14.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $873.4B +14.0% 3M
Sample peer B: $746.7B +8.4% 3M
Sample peer C: $811.4B -0.0% 3M
Sample peer D: $168.1B -3.5% 3M
Sample peer E: $179.6B +16.5% 3M